| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/1997 | US5599706 Ribozymes targeted to apo(a) mRNA |
| 02/04/1997 | US5599577 Drug delivery; gastrointestinal disorders |
| 02/04/1997 | US5599561 Method of making poultice |
| 02/04/1997 | US5599557 Stable hydrated cephalosporin dry powder for oral suspension formulation |
| 02/04/1997 | US5599552 Biodegradable polymer composition |
| 02/04/1997 | US5599551 Genital lubricants containing zinc as an anti-viral agent |
| 02/04/1997 | US5599548 Reducing or preventing the appearance of wrinkled or aged skin |
| 02/04/1997 | US5599535 Administering a non-steroidal antiinflammatory agent preventing cell lose in eye disorders |
| 02/04/1997 | US5599533 Organopolysiloxane elastomer dispersion; cosmetics |
| 02/04/1997 | US5599528 Preventing discoloration and decomposition of kojic acid in aqueous cosmetic emulsions by adding nonionic surfactants and controlling hydrophilic-lipophilic balance |
| 02/04/1997 | US5599388 Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production |
| 02/04/1997 | CA2182635A1 Process for the crystallization of macromolecules |
| 02/04/1997 | CA2179359A1 Bioavailable crystalline form of cefuroxime azetil |
| 02/04/1997 | CA2172603C Solid substances comprising valproic acid and sodium valproate |
| 02/04/1997 | CA2123332C Controlled release formulation of diltiazem hydrochloride |
| 02/04/1997 | CA2111417C Composition for treating skin diseases |
| 02/04/1997 | CA2071215C Method and composition for treating inflammatory bowel disorders |
| 02/04/1997 | CA2053820C Method of inhibiting metabolism of cholesterol |
| 02/04/1997 | CA2053190C Preparation of medicaments for treating asthma using (s)-o-fluoromethyl-histidine and esters thereof |
| 02/04/1997 | CA2050255C 1-methylcarbapenem derivatives and process for preparation thereof |
| 02/04/1997 | CA2049496C Sulfonamide derivatives |
| 02/04/1997 | CA2035693C Syrup composition |
| 02/04/1997 | CA2014202C Dichloro-substituted imidazole derivatives as antifungal agents |
| 02/04/1997 | CA2006703C Antibacterial anti-plaque oral composition |
| 02/04/1997 | CA1338895C Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical composition containing them |
| 02/04/1997 | CA1338894C Aminomethyl-chroman and thiochroman compounds as ó-2-adrenergic antagonists |
| 02/04/1997 | CA1338892C Process for the preparation of enantiomerically homogeneous aminopyrrolidinyl naphthyridine and quinolone carboxylic acids |
| 02/04/1997 | CA1338889C Morphine containing composition |
| 02/04/1997 | CA1338888C Matrix with immunomodulating activity |
| 02/03/1997 | CA2182469A1 Endothelin-receptor-antagonists |
| 01/30/1997 | WO1997003473A1 Battery pack housing device and battery pack |
| 01/30/1997 | WO1997003345A2 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna |
| 01/30/1997 | WO1997003211A1 Antisense inhibition of hepatitis b virus replication |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997003088A1 Triterpene derivatives and remedy for liver diseases |
| 01/30/1997 | WO1997003086A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | WO1997003084A1 New inhibitors of platelet aggregation |
| 01/30/1997 | WO1997003083A1 Pyrimidine nucleoside derivative |
| 01/30/1997 | WO1997003082A2 Pyrimidine nucleoside derivatives |
| 01/30/1997 | WO1997003079A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 01/30/1997 | WO1997003076A1 Heterocycle-fused thiazole derivatives |
| 01/30/1997 | WO1997003074A1 4-amino-3-acylnaphthyridine derivatives |
| 01/30/1997 | WO1997003072A1 New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds |
| 01/30/1997 | WO1997003071A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 01/30/1997 | WO1997003069A1 Heterocyclic compounds and pharmaceutical compositions containing them |
| 01/30/1997 | WO1997003068A1 A triazolylmethyl-indole ethylamine bisulfate salt |
| 01/30/1997 | WO1997003067A1 Piperazine derivatives as therapeutic agents |
| 01/30/1997 | WO1997003066A1 Substituted benzolactam compounds as substance p antagonists |
| 01/30/1997 | WO1997003065A1 Diphenylmethylene piperidine derivatives |
| 01/30/1997 | WO1997003057A1 Cyclic amides and derivatives thereof |
| 01/30/1997 | WO1997003055A1 Compounds, compositions, and methods for inhibiting replication of retroviruses and for inhibiting tumor promoter initiated transcription |
| 01/30/1997 | WO1997003054A1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/30/1997 | WO1997003050A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 01/30/1997 | WO1997003047A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors |
| 01/30/1997 | WO1997002840A1 Immunovectors for the intracellular and intranuclear transport |
| 01/30/1997 | WO1997002835A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | WO1997002833A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | WO1997002830A2 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 01/30/1997 | WO1997002829A2 Use of indigestible oligosaccharides to prevent and treat diarrhea |
| 01/30/1997 | WO1997002828A1 Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases |
| 01/30/1997 | WO1997002827A1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts |
| 01/30/1997 | WO1997002826A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 01/30/1997 | WO1997002825A1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
| 01/30/1997 | WO1997002824A1 Use of a tachykinin antagonist and a muscarinic antagonist and/or an antihistamine to treat motion sickness |
| 01/30/1997 | WO1997002823A1 Use of polyamine antagonists for the treatment of glaucoma |
| 01/30/1997 | WO1997002822A1 Drug for ameliorating brain diseases |
| 01/30/1997 | WO1997002821A2 Antifungal agent, compound therefor, process for producing the same |
| 01/30/1997 | WO1997002820A1 N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| 01/30/1997 | WO1997002819A1 2-[2-(dimethylamino)ethyl]-8,8-dipropyl-2-azaspiro[4.5]decane dimaleate |
| 01/30/1997 | WO1997002817A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | WO1997002816A1 Use of pyruvate for retarding neutrophil infiltration and morphologic loss in ischemic bowel |
| 01/30/1997 | WO1997002815A1 Flutamide composition |
| 01/30/1997 | WO1997002814A1 Use of a retinoid for preparing an antibacterial drug |
| 01/30/1997 | WO1997002813A1 Non-allosteric gabaa agonists for treating sleep disorders |
| 01/30/1997 | WO1997002810A2 Polymeric lamellar substrate particles for drug delivery |
| 01/30/1997 | WO1997002730A2 Enamel matrix related polypeptide |
| 01/30/1997 | WO1996040745A3 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
| 01/30/1997 | WO1996039126A3 Ranitidine salts on magnesium trisilicate as an adsorbate |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |
| 01/30/1997 | WO1996033724A3 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 01/30/1997 | WO1996033723A3 Use of benzamide derivatives for treating and/or preventing meniere's syndrome and motion sickness |
| 01/30/1997 | WO1996030016A3 Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| 01/30/1997 | DE19529025A1 Neue 8-bromsubstituierte cyclische Nucleotidester, Verfahren zu ihrer Herstellung und ihre Verwendung New 8-bromo-substituted cyclic Nucleotidester, processes for their preparation and their use |
| 01/30/1997 | DE19527552A1 Transketolase-verwandtes-Protein Transketolase-related protein |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226851A1 Diphenylmethylene piperidine derivatives |
| 01/30/1997 | CA2226758A1 New inhibitors of platelet aggregation |
| 01/30/1997 | CA2226658A1 Early onset alzheimer's disease gene and gene products |
| 01/30/1997 | CA2226623A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | CA2226570A1 Enamel matrix related polypeptide |
| 01/30/1997 | CA2226553A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue |
| 01/30/1997 | CA2226456A1 Cyclic amides and derivatives thereof |
| 01/30/1997 | CA2226420A1 Use of indigestible oligosaccharides to treat and prevent otitis media in humans |
| 01/30/1997 | CA2226392A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | CA2226340A1 Drug for ameliorating brain diseases |
| 01/30/1997 | CA2226297A1 Thiazoline derivatives |
| 01/30/1997 | CA2226096A1 Pyrimidine nucleoside derivatives |
| 01/30/1997 | CA2225411A1 New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds |
| 01/30/1997 | CA2224718A1 Novel quinoxaline- and quinoxalinylalkane-phosphonic acids |
| 01/30/1997 | CA2224436A1 Benzo [g] quinoline derivatives |